DURAVELO

Live / Registered — Registered (as of 08 Apr 2025)

What this means for you

Registered since 08 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79387355
Registration number
7749218
Mark type
Stylized text
Filed
04 Dec 2023
Published for opposition
18 Feb 2025
Registered
08 Apr 2025
Attorney of record
Christina M. Licursi

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical preparations for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology for the treatment of both solid and liquid tumors; pharmaceutical preparations for the treatment of urological and renal diseases; pharmaceutical preparations for the treatment of solid mass cancers, namely, bladder and urothelial cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, pancreatic cancer, ovarian cancer, esophageal cancer, prostate cancer, cervical cancer, breast cancer, penile and anal cancer, gastric cancer, and colorectal cancer; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents
  • Class 042 — Scientific and technological services: Medical research services, namely, scientific, clinical, and pharmacological medical research services; scientific research for medical purposes in the field of cancerous diseases; scientific and technological services, namely, scientific research and analysis and providing scientific research information in the field of oncology for both solid and liquid tumors, urological and renal diseases, and the treatment of solid mass cancers, namely, bladder and urothelial cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, pancreatic cancer, ovarian cancer, esophageal cancer, prostate cancer, cervical cancer, breast cancer, penile and anal cancer, gastric cancer, and colorectal cancer; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting medical trials; providing of medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research in the field of oncology

Owner

Prosecution history

  • 07 Nov 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 19 Oct 2025 — FINAL DISPOSITION NOTICE SENT TO IB
  • 19 Oct 2025 — FINAL DISPOSITION PROCESSED
  • 08 Jul 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 27 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 10 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 10 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 08 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 08 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
  • 01 Apr 2025 — ASSIGNED TO EXAMINER
  • 26 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 26 Mar 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
  • 26 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 26 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 26 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

View this trademark record on Marksy